Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - ImmunityBio, Inc. | nk-10q_20180630.htm |
| EX-32.2 - EX-32.2 - ImmunityBio, Inc. | nk-ex322_6.htm |
| EX-31.2 - EX-31.2 - ImmunityBio, Inc. | nk-ex312_8.htm |
| EX-31.1 - EX-31.1 - ImmunityBio, Inc. | nk-ex311_9.htm |
| EX-10.2 - EX-10.2 - ImmunityBio, Inc. | nk-ex102_65.htm |
| EX-10.1 - EX-10.1 - ImmunityBio, Inc. | nk-ex101_64.htm |
Exhibit 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. § 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Patrick Soon-Shiong, the chief executive officer of NantKwest, Inc. (the “Company”), certify for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
|
|
i. |
the Quarterly Report of the Company on Form 10-Q for the quarter ended June 30, 2018 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|
|
ii. |
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: August 6, 2018 |
By: |
|
/s/ Patrick Soon-Shiong |
|
|
|
|
Patrick Soon-Shiong |
|
|
|
|
Chief Executive Officer (Principal Executive Officer) |